New drug target offers hope for treating deadly lung scarring disease

Researchers have identified a way to block a protein called OGG1 that appears to drive pulmonary fibrosis, a fatal lung disease affecting hundreds of thousands globally. The finding could lead to the first effective treatment for a condition that currently has no cure and kills patients within 2-5 years of diagnosis.

Originaltitel: Small-molecule-mediated OGG1 inhibition attenuates pulmonary inflammation and lung fibrosis in a murine lung fibrosis model